Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Build, Sell Automated Protein Array System Developed With NextGen

NEW YORK, March 12 - PerkinElmer will build and sell a new automated system for processing protein microarrays co-developed by its Life Sciences division and NextGen Sciences.
 
Under the terms of this agreement, PerkinElmer Life Sciences will manufacture and have exclusive worldwide distribution rights for the system, called the ProteinArray workstation.

Financial details of the deal were not disclosed. However, Jim Monahan, a spokesman for PerkinElmer Life Sciences, told GenomeWeb that the tool itself "is still in the developmental stage."

He added that the workstation, which will be showcased at a microarray conference next week, will be ready to hit the market sometime in September.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.